Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Valentina Ancarani
Observed names:
Ancarani Valentina,
Ancarani, Valentina,
Ancarani, Valentina <1978>,
V. Ancarani
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Istituti di Ricovero e Cura a Carattere Scientifico,
Boehringer Ingelheim (United States),
University of Turin,
University of Montana,
University of Bologna
show all 6
ORCID:
0000-0001-7571-8605
Observed ORCID:
0000-0001-7571-8605
OpenAlex ID:
A5002734384
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
2013
·
Laura Ridolfi
, Massimiliano Petrini
, et al.
·
Journal of Translational Medicine
·
75
PDF
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer
2022
·
Lucia Mazzotti
, Anna Gaimari
, et al.
·
International Journal of Molecular Sciences
·
70
PDF
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
2019
·
Jenny Bulgarelli
, Marcella Tazzari
, et al.
·
Frontiers in Immunology
·
50
PDF
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome
2011
·
Laura Ridolfi
, Massimiliano Petrini
, et al.
·
Melanoma Research
·
41
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
2017
·
Francesco de Rosa
, Laura Ridolfi
, et al.
·
Melanoma Research
·
38
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study
2014
·
Francesco de Rosa
, Laura Ridolfi
, et al.
·
Journal of Translational Medicine
·
32
PDF
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
2021
·
Jenny Bulgarelli
, Claudia Piccinini
, et al.
·
Frontiers in Immunology
·
26
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell‐Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis
2010
·
Laura Ridolfi
, Massimiliano Petrini
, et al.
·
Journal of Immunology Research
·
26
PDF
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
2024
·
Laura Ridolfi
, Lorena Gurrieri
, et al.
·
Frontiers in Immunology
·
24
PDF
Effects of yoga practice on physiological distress, fatigue and QOL in patients affected by breast cancer undergoing adjuvant radiotherapy
2022
·
Simona Micheletti
, Patrizia Serra
, et al.
·
Technical Innovations & Patient Support in Radiation Oncology
·
24
PDF
[Os(bpy)2(CO)(enIA)][OTf]2: A Novel Sulfhydryl−Specific Metal−Ligand Complex
2005
·
Claudio Garino
, Simona Ghiani
, et al.
·
Inorganic Chemistry
·
21
Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”
2011
·
Laura Ridolfi
, Massimiliano Petrini
, et al.
·
Clinical and Developmental Immunology
·
19
PDF
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value
2023
·
Ivan Vannini
, Tania Rossi
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
11
PDF
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
2018
·
Laura Ridolfi
, Francesco de Rosa
, et al.
·
BMJ Open
·
11
PDF
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial
2025
·
Jenny Bulgarelli
, Claudia Piccinini
, et al.
·
Journal of Translational Medicine
·
9
PDF
FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
2010
·
Laura Fiammenghi
, Valentina Ancarani
, et al.
·
Journal of Translational Medicine
·
6
PDF
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS ‐ CoV ‐2 in Exposed Individuals From Emilia Romagna Region and COVID ‐19 Severity
2025
·
Lucia Mazzotti
, Patricia Borges de Souza
, et al.
·
HLA
·
5
PDF
The Comprehensive Cancer Care Network of Romagna: The Opportunities Generated by the OECI Accreditation Program
2015
·
Valentina Ancarani
, Marna Bernabini
, et al.
·
Tumori Journal
·
5
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose interleukin-2: Interim analysis data.
2015
·
Laura Ridolfi
, Francesco De Rosa
, et al.
·
Journal of Clinical Oncology
·
3
Low-dose temozolomide modulation of peripheral blood regulatory T cells before dendritic cell-based vaccination in metastatic melanoma: Phase I/II study.
2010
·
L. Ridolfi
, L. Fiammenghi
, et al.
·
Journal of Clinical Oncology
·
2
397 Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanoma
2025
·
Marcella Tazzari
, Silvia Carloni
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
1
159P Unveiling the impact of DC vaccination on systemic immunity in advanced malignant melanoma: Preliminary results from the ABSIDE study
2024
·
G.N. Sabatino
, D. Fanelli
, et al.
·
Immuno-Oncology Technology
·
1
PDF
49P A phase II randomized trial with adjuvant autologous tumor lysate-pulsed dendritic cells (DC) in resected stage III-IV melanoma patients: Preliminary immunological results
2021
·
L. Ridolfi
, J. Bulgarelli
, et al.
·
Annals of Oncology
·
1
Fluorescence microscopy imaging to monitor dendritic cell's tumor lysate capturing and processing: Preliminary data
2007
·
Valentina Ancarani
, Laura Fiammenghi
, et al.
·
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
·
1
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine
2026
·
Lucia Mazzotti
, Gerardo Musuraca
, et al.
·
Frontiers in Immunology
PDF
Show more works
View as search
Works count:
44
Citation count:
502
H-index:
12
I10-index:
14
Year
Topic
Type